| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Are You Helping Yourself or Hurting Yourself When You Network? |
|
Main Subject - Are You Helping Yourself or Hurting Yourself When You Network?
We all talk about networking. We all seem to know that networking has something to do wit According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product h meeting enough folks to continue to build our referral network, which in turn will cont ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in nue to build our businesses. Referrals come when someone you’ve met likes you and believ lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. s you can offer the solution to someone else’s problem. So, if the goal in networking is here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe o have someone like us, and possibly offer us a referral, then why do people make the mis d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ake of engaging in conversations that do not promote relationships? My mother attended a ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc party last week. She met a radio personality who immediately began talking politics with easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi my mother. As often happens, the two did not agree and a strong debate developed. Both pa nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ties walked away very unhappy with the other. Neither is going to receive a referral as a and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ result of this meeting. I personally do not discuss politics with those whose opinions a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi e strongly different than mine. It’s also not a topic I would introduce to a total strang ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a er. No good can come of it. Another mistake I see folks make is talking negatively about dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod other people. It does not matter if the person is a famous movie star or the neighbor aro cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin nd the corner, when we speak poorly of others, it does not endear others to us. I am con tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen tantly surprised when I meet people and I later find out they know someone that I know. W t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel at if I had spoken poorly of this person? What if I had said unkind things? When I meet ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust new people, I ask about them. I truly want to know about them. My views on politics are n y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products t relevant, nor are my views on the folks next door. What is important is my genuine inte . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de est in the person I’m speaking to. If you truly want to network, in an effort to build y elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ur referral network, then be careful about the topics and people you choose to talk about tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Some Secrets to Employment Security If You Want Good Health, Plan for It - If You Want GREAT Health Plan and Do a Postmortem Quality Staffing: Stop Placing the Wrong People in the Wrong Jobs
|